{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T22:22:43Z","timestamp":1772058163725,"version":"3.50.1"},"reference-count":73,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00037","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T11:10:03Z","timestamp":1486465803000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat"],"prefix":"10.3389","volume":"8","author":[{"given":"Gema","family":"Vera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana E.","family":"L\u00f3pez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Uranga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Gir\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Isabel","family":"Mart\u00edn-Fontelles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Abalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1002","DOI":"10.1111\/j.1365-2982.2009.01315.x","article-title":"Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat","volume":"21","author":"Abalo","year":"2009","journal-title":"Neurogastroenterol. Motil."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e694","DOI":"10.1111\/j.1365-2982.2009.01466.x","article-title":"The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat","volume":"22","author":"Abalo","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1111\/j.1365-2982.2011.01677.x","article-title":"Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors","volume":"23","author":"Abalo","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1111\/nmo.12073","article-title":"Cannabinoids may worsen gastric dysmotility induced by chronic cisplatin in the rat","volume":"25","author":"Abalo","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1111\/nmo.12668","article-title":"In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat","volume":"27","author":"Abalo","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"key":"B6","doi-asserted-by":"crossref","first-page":"c0255","DOI":"10.1016\/B978-0-12-800756-3.00051-X","article-title":"Cannabis, cannabinoids, and visceral pain","volume-title":"Handbook of Cannabis and Related Pathologies","author":"Abalo","year":"2017"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12952","article-title":"May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat","author":"Abalo","year":"2016","journal-title":"Neurogastroenterol. Motil."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000339072","article-title":"The gastrointestinal pharmacology of cannabinoids: focus on motility","volume":"90","author":"Abalo","year":"2012","journal-title":"Pharmacology"},{"key":"B9","first-page":"81","article-title":"Cannabinoids and gastrointestinal motility: animal and human studies","volume":"12","author":"Aviello","year":"2008","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.mph.0000172751.06286.5b","article-title":"Itraconazole-related increased vincristine neurotoxicity: case report and review of literature","volume":"27","author":"Berm\u00fadez","year":"2005","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"B11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-642-69928-3_15","article-title":"The effect of cyclophosphamide and vincristine on intestinal protein loss in rats","volume":"8","author":"Ber\u00f3","year":"1985","journal-title":"Arch. Toxicol. Suppl."},{"key":"B12","first-page":"613","article-title":"Vincristine in the treatment of lymphomas and leukemias","volume":"23","author":"Bohannon","year":"1963","journal-title":"Cancer Res."},{"key":"B13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/bmj.3.5609.58","article-title":"Side-effects of Vinca alkaloids","volume":"3","author":"Bradley","year":"1968","journal-title":"Br. Med. J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.autneu.2008.05.004","article-title":"Radiological study of gastrointestinal motor activity after acute cisplatin in the rat. Temporal relationship with pica","volume":"141","author":"Cabezos","year":"2008","journal-title":"Auton Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1111\/j.1365-2982.2010.01483.x","article-title":"Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica","volume":"22","author":"Cabezos","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"key":"B16","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3346\/jkms.1998.13.3.33z","article-title":"Overdose of vincristine: experience with a patient","volume":"13","author":"Chae","year":"1998","journal-title":"J. Korean Med. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1365-2982.2008.01114.x","article-title":"Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase","volume":"20","author":"de Filippis","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1097\/MPH.0b013e3181d7742f","article-title":"Vincristine and intestinal pseudo-obstruction in children: report of 5 cases, literature review, and suggested management","volume":"32","author":"Diezi","year":"2010","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"G78","DOI":"10.1152\/ajpgi.90285.2008","article-title":"Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats","volume":"295","author":"Duncan","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00280-010-1339-4","article-title":"Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT3 receptor antagonists","volume":"67","author":"du Sert","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3109\/08880018.2013.837129","article-title":"Exploring the attitudes of pediatric oncologists toward the use of laxatives for the prevention of constipation in patients undergoing active treatment: a canadian perspective","volume":"31","author":"Essa","year":"2014","journal-title":"Pediatr. Hematol. Oncol."},{"key":"B22","first-page":"1309","article-title":"Metoclopramide in vincristine-induced ileus","volume":"69","author":"Garewal","year":"1985","journal-title":"Cancer Treat. Rep."},{"key":"B23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-2999(96)00279-8","article-title":"123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors","volume":"307","author":"Gatley","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"B24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.5694\/j.1326-5377.1977.tb114646.x","article-title":"Lactulose in vincristine-induced constipation","volume":"2","author":"Harris","year":"1977","journal-title":"Med. J. Aust."},{"key":"B25","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1476-5381.2009.00625.x","article-title":"GPR55 ligands promote receptor coupling to multiple signalling pathways","volume":"160","author":"Henstridge","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1476-5381.2009.00176.x","article-title":"Opportunities for the replacement of animals in the study of nausea and vomiting","volume":"157","author":"Holmes","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1007\/s00221-014-3985-y","article-title":"Measuring the nausea-to-emesis continuum in non-human animals: refocusing on gastrointestinal vagal signaling","volume":"232","author":"Horn","year":"2014","journal-title":"Exp. Brain Res."},{"key":"B28","doi-asserted-by":"crossref","first-page":"PL115","DOI":"10.1016\/S0024-3205(97)00596-1","article-title":"AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain","volume":"61","author":"Hosohata","year":"1997","journal-title":"Life Sci."},{"key":"B29","first-page":"207","article-title":"Vincristine-induced paralytic ileus: role of fiberoptic colonoscopy and prostaglandin F2 alpha","volume":"87","author":"Ikehara","year":"1992","journal-title":"Am. J. Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.phrs.2009.03.008","article-title":"Cannabinoids in intestinal inflammation and cancer","volume":"60","author":"Izzo","year":"2009","journal-title":"Pharmacol. Res."},{"key":"B31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(99)00673-1","article-title":"The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats","volume":"384","author":"Izzo","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pharmthera.2009.12.005","article-title":"Cannabinoids and the gut: new developments and emerging concepts","volume":"126","author":"Izzo","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"B33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00292876","article-title":"Treatment of vincristine-induced ileus with sincalide, a cholecystokinin analog","volume":"8","author":"Jackson","year":"1982","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B34","first-page":"1016","article-title":"Antitumor principles derived from Vinca rosea Linn. I. Vincaleukoblastine and leurosine","volume":"20","author":"Johnson","year":"1960","journal-title":"Cancer Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1023\/A:1010785206315","article-title":"Effect of vincristine on gastric motility in conscious rats","volume":"46","author":"Kaneko","year":"2001","journal-title":"Dig. Dis. Sci."},{"key":"B36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/jm980363y","article-title":"Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists","volume":"42","author":"Lan","year":"1999","journal-title":"J. Med. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0014-2999(02)02053-8","article-title":"Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors","volume":"450","author":"Landi","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1097\/MPH.0b013e318257a4ae","article-title":"A case of severe toxicity during coadministration of vincristine and piperacillin: are drug transporters involved in vincristine hypersensitivity and drug-drug interactions?","volume":"34","author":"Le Guellec","year":"2012","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1353-8020(97)00008-4","article-title":"Vincristine-induced paralytic ileus in Parkinson's disease","volume":"3","author":"Leker","year":"1997","journal-title":"Parkinsonism Relat. Disord."},{"key":"B40","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s11096-009-9323-y","article-title":"Paralytic ileus possibly associated with interaction between ritonavir\/lopinavir and vincristine","volume":"31","author":"Lev\u00eaque","year":"2009","journal-title":"Pharm. World Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuropharm.2013.03.029","article-title":"A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice","volume":"71","author":"Li","year":"2013b","journal-title":"Neuropharmacology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e67427","DOI":"10.1371\/journal.pone.0067427","article-title":"The dual effect of cannabinoid receptor-1 deficiency on the murine postoperative ileus","volume":"8","author":"Li","year":"2013a","journal-title":"PLoS ONE"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1111\/j.1365-2982.2009.01419.x","article-title":"Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus","volume":"22","author":"Li","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e862","DOI":"10.1111\/j.1365-2982.2011.01742.x","article-title":"A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents","volume":"23","author":"Lin","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1096\/fj.02-0338fje","article-title":"The endocannabinoid system and the molecular basis of paralytic ileus in mice","volume":"16","author":"Mascolo","year":"2002","journal-title":"FASEB J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/jsap.12237","article-title":"Gastrointestinal toxicity after vincristine or cyclophosphamide administered with or without maropitant in dogs: a prospective randomised controlled study","volume":"55","author":"Mason","year":"2014","journal-title":"J. Small Anim. Pract."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/sj.bjp.0705889","article-title":"Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats","volume":"142","author":"Mathison","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1111\/nmo.12890","article-title":"Gastrointestinal dysfunction and enteric neurotoxicity following treatment with anticancer chemotherapeutic agent 5-fluorouracil","volume":"28","author":"McQuade","year":"2016","journal-title":"Neurogastroenterol. Motil."},{"key":"B49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40265-013-0019-1","article-title":"Management of chemotherapy-induced nausea and vomiting focus on newer agents and new uses for older agents","volume":"73","author":"Navari","year":"2013","journal-title":"Drugs"},{"key":"B50","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1590\/S0100-879X2009000600015","article-title":"Vincristine delays gastric emptying and gastrointestinal transit of liquid in awake rats","volume":"42","author":"Peixoto J\u00fanior","year":"2009","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B51","doi-asserted-by":"crossref","first-page":"733","DOI":"10.7326\/0003-4819-80-6-733","article-title":"Vincristine neurotoxicity","volume":"80","author":"Rosenthal","year":"1974","journal-title":"Ann. Intern. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fphar.2016.00263","article-title":"Profile of antiemetic activity of netupitant alone or in combination with palonosetron and dexamethasone in ferrets and Suncus murinus (House Musk Shrew)","volume":"7","author":"Rudd","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B53","doi-asserted-by":"crossref","first-page":"c0280","DOI":"10.1016\/B978-0-12-800756-3.00056-9","article-title":"Cannabis and cannabinoids and the effects on gastrointestinal function: an overview","volume-title":"Handbook of Cannabis and Related Pathologies","author":"Salaga","year":"2017"},{"key":"B54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1155\/2011\/953975","article-title":"Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases","volume":"25","author":"Schicho","year":"2011","journal-title":"Can. J. Gastroenterol."},{"key":"B55","first-page":"331","article-title":"A study of the effect of vinca alkaloid 'vinblastine' on gastrointestinal motility in rats","volume":"239","author":"Sharma","year":"1979","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"B56","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/0016-5085(88)90404-0","article-title":"Vincristine and gastrointestinal transit","volume":"95","author":"Sharma","year":"1988","journal-title":"Gastroenterology"},{"key":"B57","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/jnnp.30.6.506","article-title":"The myenteric plexus in drug-induced neuropathy","volume":"30","author":"Smith","year":"1967","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"B58","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0016-5085(87)90144-2","article-title":"Vincristine alters myoelectric activity and transit of the small intestine in rats","volume":"92","author":"Sninsky","year":"1987","journal-title":"Gastroenterology"},{"key":"B59","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0091-3057(93)90126-E","article-title":"Pica in rats is analogous to emesis: an animal model in emesis research","volume":"45","author":"Takeda","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B60","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/pgmj.46.535.330","article-title":"Death from paralytic ileus following vincristine therapy","volume":"46","author":"Toghill","year":"1970","journal-title":"Postgrad. Med. J."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1939-1676.2011.00795.x","article-title":"Ultrasonographic evaluation of vincristine-induced gastric hypomotility and the prokinetic effect of mosapride in dogs","volume":"25","author":"Tsukamoto","year":"2011","journal-title":"J. Vet. Intern. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB2 receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1592\/phco.2005.25.7.1011","article-title":"Long-term clinical outcome after accidental overdose of multiple chemotherapeutic agents","volume":"25","author":"Uner","year":"2005","journal-title":"Pharmacotherapy"},{"key":"B64","first-page":"349","article-title":"Vincristine neurotoxicity in rodents","volume":"121","author":"Uy","year":"1967","journal-title":"Johns Hopkins Med. J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1111\/j.1365-2982.2011.01674.x","article-title":"Enteric neuropathy evoked by repeated cisplatin in the rat","volume":"23","author":"Vera","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"B66","doi-asserted-by":"crossref","first-page":"c0570","DOI":"10.1016\/B978-0-12-800756-3.00114-9","article-title":"Cannabinoids and the effects on gastrointestinal tract: a focus on motility","volume-title":"Handbook of Cannabis and Related Pathologies","author":"Vera","year":"2017"},{"key":"B67","first-page":"153","article-title":"The CB1-selective cannabinoid antagonist AM251 partially prevents gastrointestinal dysmotility induced by the antitumoral drug vincristine in the rat","volume":"24","author":"Vera","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/s00221-014-3954-5","article-title":"X-ray analysis of the effect of the 5-HT3 receptor antagonist granisetron on gastrointestinal motility in rats repeatedly treated with the antitumoral drug cisplatin","volume":"232","author":"Vera","year":"2014","journal-title":"Exp. Brain Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fnins.2013.00030","article-title":"Effects of oxaliplatin on mouse myenteric neurons and colonic motility","volume":"7","author":"Wafai","year":"2013","journal-title":"Front. Neurosci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/jjco\/hyd132","article-title":"Vincristine-induced dysphagia suggesting esophageal motor dysfunction: a case report","volume":"30","author":"Wang","year":"2000","journal-title":"Jpn. J. Clin. Oncol."},{"key":"B71","first-page":"173","article-title":"Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome","volume":"2","author":"Waterlow","year":"2008","journal-title":"Core Evid."},{"key":"B72","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/sj.bjp.0707486","article-title":"Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation","volume":"153","author":"Wright","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"471","DOI":"10.5414\/CP202584","article-title":"Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients","volume":"54","author":"Yasu","year":"2016","journal-title":"Int. J. Clin. Pharmacol. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00037\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:38:05Z","timestamp":1601599085000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00037\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,6]]},"references-count":73,"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00037","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,6]]}}}